These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 1383099)

  • 1. Does the somatostatin analogue octreotide protect against ERCP induced pancreatitis?
    Binmoeller KF; Harris AG; Dumas R; Grimaldi C; Delmont JP
    Gut; 1992 Aug; 33(8):1129-33. PubMed ID: 1383099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of octreotide-acetate in preventing pancreatitis-like changes following therapeutic endoscopic retrograde cholangiopancreatography.
    Duvnjak M; Supanc V; Simicević VN; Hrabar D; Troskot B; Smircić-Duvnjak L; Bekavac-Beslin M
    Acta Med Croatica; 1999; 53(3):115-8. PubMed ID: 10705631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multicenter, randomized, controlled trial to evaluate the effect of prophylactic octreotide on ERCP-induced pancreatitis.
    Sternlieb JM; Aronchick CA; Retig JN; Dabezies M; Saunders F; Goosenberg E; Infantolino A; Ionna S; Maislin G; Wright SH
    Am J Gastroenterol; 1992 Nov; 87(11):1561-6. PubMed ID: 1279967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of long-acting somatostatin analogue on enzyme changes after endoscopic pancreatography.
    Tulassay Z; Papp J
    Gastrointest Endosc; 1991; 37(1):48-50. PubMed ID: 1706282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of a long-acting somatostatin analogue (octreotide) for prophylaxis of acute pancreatitis after endoscopic sphincterotomy.
    Arcidiacono R; Gambitta P; Rossi A; Grosso C; Bini M; Zanasi G
    Endoscopy; 1994 Nov; 26(9):715-8. PubMed ID: 7536155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Octreotide in the prevention of pancreatic injury associated with endoscopic cholangiopancreatography.
    Tulassay Z; Döbrönte Z; Prónai L; Zágoni T; Juhász L
    Aliment Pharmacol Ther; 1998 Nov; 12(11):1109-12. PubMed ID: 9845400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of octreotide on the prevention of acute pancreatitis and hyperamylasemia after diagnostic and therapeutic ERCP.
    Arvanitidis D; Hatzipanayiotis J; Koutsounopoulos G; Frangou E
    Hepatogastroenterology; 1998; 45(19):248-52. PubMed ID: 9496522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can somatostatin prevent injection pancreatitis after ERCP?
    Persson B; Slezak P; Efendic S; Häggmark A
    Hepatogastroenterology; 1992 Jun; 39(3):259-61. PubMed ID: 1380475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of octreotide versus placebo in the prevention of post-ERCP pancreatitis.
    Kisli E; Baser M; Aydin M; Guler O
    Hepatogastroenterology; 2007; 54(73):250-3. PubMed ID: 17419271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk Factors for Post-Endoscopic Retrograde Cholangiopancreatography (ERCP) Pancreatitis and the Effect of Octreotide Combined with Nonsteroidal Anti-Inflammatory Drugs on Preventing Its Occurrence.
    Wang J; Shen Y; Zhong Z; Wu S; Zheng L
    Med Sci Monit; 2018 Dec; 24():8964-8969. PubMed ID: 30531679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Octreotide in the prevention of hyperamylasemia following ERCP (a controlled multicenter study)].
    Döbrönte Z; Juhász L; Tulassay Z
    Orv Hetil; 1996 Oct; 137(42):2309-12. PubMed ID: 8992429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No Benefit of Oral Diclofenac on Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis.
    Ishiwatari H; Urata T; Yasuda I; Matsusaki S; Hisai H; Kawakami H; Ono M; Iwashita T; Doi S; Kawakubo K; Hayashi T; Sonoda T; Sakamoto N; Kato J
    Dig Dis Sci; 2016 Nov; 61(11):3292-3301. PubMed ID: 27447477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous bolus somatostatin after diagnostic cholangiopancreatography reduces the incidence of pancreatitis associated with therapeutic endoscopic retrograde cholangiopancreatography procedures: a randomised controlled trial.
    Poon RT; Yeung C; Liu CL; Lam CM; Yuen WK; Lo CM; Tang A; Fan ST
    Gut; 2003 Dec; 52(12):1768-73. PubMed ID: 14633959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Octreotide versus hydrocortisone versus placebo in the prevention of post-ERCP pancreatitis: a multicenter randomized controlled trial.
    Manolakopoulos S; Avgerinos A; Vlachogiannakos J; Armonis A; Viazis N; Papadimitriou N; Mathou N; Stefanidis G; Rekoumis G; Vienna E; Tzourmakliotis D; Raptis SA
    Gastrointest Endosc; 2002 Apr; 55(4):470-5. PubMed ID: 11923756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gabexate for the prevention of pancreatic damage related to endoscopic retrograde cholangiopancreatography. Gabexate in digestive endoscopy--Italian Group.
    Cavallini G; Tittobello A; Frulloni L; Masci E; Mariana A; Di Francesco V
    N Engl J Med; 1996 Sep; 335(13):919-23. PubMed ID: 8786777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prophylactic effect of somatostatin on post-ERCP pancreatitis: a randomized controlled trial.
    Poon RT; Yeung C; Lo CM; Yuen WK; Liu CL; Fan ST
    Gastrointest Endosc; 1999 May; 49(5):593-8. PubMed ID: 10228257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antisecretory agents for prevention of post-ERCP pancreatitis: rationale for use and clinical results.
    Poon RT; Fan ST
    JOP; 2003 Jan; 4(1):33-40. PubMed ID: 12555014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of diclofenac plus somatostatin in the prevention of post-ERCP pancreatitis: a randomized, double-blind, placebo-controlled trial.
    Katsinelos P; Fasoulas K; Paroutoglou G; Chatzimavroudis G; Beltsis A; Terzoudis S; Katsinelos T; Dimou E; Zavos C; Kaltsa A; Kountouras J
    Endoscopy; 2012 Jan; 44(1):53-9. PubMed ID: 22198776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of octreotide administration in the prophylaxis of post-ERCP pancreatitis and hyperamylasemia: A multicenter, placebo-controlled, randomized clinical trial.
    Li ZS; Pan X; Zhang WJ; Gong B; Zhi FC; Guo XG; Li PM; Fan ZN; Sun WS; Shen YZ; Ma SR; Xie WF; Chen MH; Li YQ
    Am J Gastroenterol; 2007 Jan; 102(1):46-51. PubMed ID: 17266687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term prophylactic administration of octreotide reduces the rise in serum amylase after endoscopic procedures on Vater's papilla.
    Testoni PA; Lella F; Bagnolo F; Caporuscio S; Cattani L; Colombo E; Buizza M
    Pancreas; 1996 Jul; 13(1):61-5. PubMed ID: 8783335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.